Carlsmed, Inc. (CARL) vs Eikon Therapeutics, Inc. Common Stock (EIKN)
A side-by-side comparison of Carlsmed, Inc. and Eikon Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CARL
Carlsmed, Inc.
$14.93HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
EIKN
Eikon Therapeutics, Inc. Common Stock
$7.65HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
Total return — CARL vs EIKN
growth of $100 · dividends reinvested · last 1yCARL +35.5% (+35.5%/yr)EIKN -49.7% (-49.7%/yr)CARL compounded faster over this window
CARL EIKN
CARL vs EIKN: by the numbers
- •EIKN is the larger company ($414M vs $406M market cap).
- •Both run net losses; EIKN's is the smaller (0.00% vs -57.42% net margin).
Metrics side by side
Valuation
| Metric | CARL | EIKN |
|---|---|---|
| P/S ratio | 6.41 | N/A |
| P/B ratio | 4.82 | 0.89 |
Profitability
| Metric | CARL | EIKN |
|---|---|---|
| Gross margin | 76.63% | 0.00% |
| Operating margin | -61.09% | 0.00% |
| Net margin | -57.42% | 0.00% |
| ROE | -43.14% | -69.06% |
| ROIC | -36.54% | -46.16% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.